Vaxart, Inc. To Present At The Mucosal Immunology Conference In Berlin On July 17, 2015

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vaxart, Inc., a privately held, clinical-stage company developing vaccines that are administered by tablet rather than by injection, today announced that Vaxart Founder and Chief Scientific Officer Dr. Sean Tucker, PhD, will present clinical data from its seasonal flu vaccine program at the upcoming Society for Mucosal Immunology Conference in Berlin.

Help employers find you! Check out all the jobs and post your resume.

Back to news